The RNA-Binding Protein HuR Posttranscriptionally Regulates the Protumorigenic Activator YAP1 in Pancreatic Ductal Adenocarcinoma.

Authors

• Samantha Z Brown
• Grace A McCarthy
• James R Carroll
• Roberto Di Niro
• Carl Pelz
• Aditi Jain
• Thomas L Sutton
• Hannah D Holly
• Avinoam Nevler
• Christopher W Schultz
• Matthew D McCoy
• Joseph A Cozzitorto
• Wei Jiang
• Charles J Yeo
• Dan A Dixon
• Rosalie C Sears
• Jonathan R Brody

Publication/Presentation Date

7-21-2022

Abstract

Yes-associated protein 1 (YAP1) is indispensable for the development of mutant

Volume

42

Issue

7

First Page

0001822

Last Page

0001822

ISSN

1098-5549

Published In/Presented At

Brown, S. Z., McCarthy, G. A., Carroll, J. R., Di Niro, R., Pelz, C., Jain, A., Sutton, T. L., Holly, H. D., Nevler, A., Schultz, C. W., McCoy, M. D., Cozzitorto, J. A., Jr, Jiang, W., Yeo, C. J., Dixon, D. A., Sears, R. C., & Brody, J. R. (2022). The RNA-Binding Protein HuR Posttranscriptionally Regulates the Protumorigenic Activator YAP1 in Pancreatic Ductal Adenocarcinoma. Molecular and cellular biology, 42(7), e0001822. https://doi.org/10.1128/mcb.00018-22

Disciplines

Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods

PubMedID

35703534

Department(s)

Administration and Leadership

Document Type

Article